日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach

揭示化脓性汗腺炎误诊和漏诊的负担:一种机器学习方法

Kirby, Joslyn; Kim, Katherine; Zivkovic, Marko; Wang, Siwei; Garg, Vishvas; Danavar, Akash; Li, Chao; Chen, Naijun; Garg, Amit

Plant regeneration through somatic embryogenesis in cell suspensions of Cenchrus ciliaris L

利用毛茛(Cenchrus ciliaris L)细胞悬浮液进行体细胞胚胎发生实现植物再生

Goyal, Shipra; Chatterjee, Vijaya; Kulkarni, Vishvas M; Bhat, Vishnu

Emerging Pathophysiological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: An Old Wine in a New Bottle

糖尿病与阿尔茨海默病之间新兴的病理生理机制:旧瓶装新酒

Patel, Vishvas N; Chorawala, Mehul R; Shah, Maitri B; Shah, Kashvi C; Dave, Bhavarth P; Shah, Manal P; Patel, Tanvi M

Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis

COVID-19 大流行期间接受靶向免疫调节剂治疗的免疫介导疾病患者的医疗资源利用情况:一项回顾性索赔分析

Bergman, Martin; Saffore, Christopher D; Kim, Katherine J; Patel, Pankaj A; Garg, Vishvas; Xuan, Si; Naik, Haley B

A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis

一项针对中重度类风湿性关节炎成人患者的乌帕替尼与托法替尼的匹配调整间接比较研究

Edwards, Christopher J; Sawant, Ruta; Garg, Vishvas; Du, Ella X; Friedman, Alan; Betts, Keith A

Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study

发生其他免疫介导表现的风险:一项回顾性匹配队列研究

Aletaha, Daniel; Epstein, Andrew J; Skup, Martha; Zueger, Patrick; Garg, Vishvas; Panaccione, Remo

Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review

非医疗原因导致原研生物制剂转换为生物类似药的经济影响:系统性文献综述

Liu, Yifei; Yang, Min; Garg, Vishvas; Wu, Eric Q; Wang, Jessie; Skup, Martha

Book Review: Environmental Pollutants and Their Bioremediation Approaches

书评:《环境污染物及其生物修复方法》

Zhang, Yong-Hong; Xia, Zhi-Ning; Yan, Li; Liu, Shu-Shen; Chowdhary, Pankaj; Hare, Vishvas; Raj, Abhay

Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial

MUSICA试验结果显示,接受两种不同剂量甲氨蝶呤联合阿达木单抗治疗的类风湿性关节炎患者,其患者报告结局均有相似改善。

Kaeley, Gurjit S; MacCarter, Daryl K; Goyal, Janak R; Liu, Shufang; Chen, Kun; Griffith, Jennifer; Kupper, Hartmut; Garg, Vishvas; Kalabic, Jasmina

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

参与阿达木单抗(修美乐)患者支持计划对类风湿性关节炎治疗过程的影响:PASSION 研究的结果

Van den Bosch, Filip; Ostor, Andrew J K; Wassenberg, Siegfried; Chen, Naijun; Wang, Chen; Garg, Vishvas; Kalabic, Jasmina